To analyze the prevalence of HBOC with BRCA1 and BRCA2 germline mutations, we recruited 135 breast and/or ovarian cancer survivors and extracted DNA from their peripheral blood lymphocytes. The gene discussed is BRCA1; the disease is ovarian cancer.